中国社区医师
中國社區醫師
중국사구의사
Chinese Community Doctors
2015年
6期
28-28,30
,共2页
布地奈德%支气管哮喘%疗效%肺功能
佈地奈德%支氣管哮喘%療效%肺功能
포지내덕%지기관효천%료효%폐공능
Budesonide%Bronchial asthma%Efficacy%Lung function
目的:分析布地奈德治疗支气管哮喘急性发作的疗效及对肺功能的影响。方法:2012年4月-2014年4月收治支气管哮喘急性发作患者104例,分成对照组与研究组,每组52例。对照组应用常规治疗,研究组在对照组基础上加用布地奈德混悬液雾化吸入治疗,观察两组治疗前后临床积分、常规指标和肺功能指标情况。结果:治疗后研究组临床症状积分低于对照组,常规指标均较对照组明显改善(P<0.05)。治疗后研究组肺功能改善显著好于对照组(P<0.05)。结论:布地奈德治疗支气管哮喘急性发作疗效显著,值得临床推广使用。
目的:分析佈地奈德治療支氣管哮喘急性髮作的療效及對肺功能的影響。方法:2012年4月-2014年4月收治支氣管哮喘急性髮作患者104例,分成對照組與研究組,每組52例。對照組應用常規治療,研究組在對照組基礎上加用佈地奈德混懸液霧化吸入治療,觀察兩組治療前後臨床積分、常規指標和肺功能指標情況。結果:治療後研究組臨床癥狀積分低于對照組,常規指標均較對照組明顯改善(P<0.05)。治療後研究組肺功能改善顯著好于對照組(P<0.05)。結論:佈地奈德治療支氣管哮喘急性髮作療效顯著,值得臨床推廣使用。
목적:분석포지내덕치료지기관효천급성발작적료효급대폐공능적영향。방법:2012년4월-2014년4월수치지기관효천급성발작환자104례,분성대조조여연구조,매조52례。대조조응용상규치료,연구조재대조조기출상가용포지내덕혼현액무화흡입치료,관찰량조치료전후림상적분、상규지표화폐공능지표정황。결과:치료후연구조림상증상적분저우대조조,상규지표균교대조조명현개선(P<0.05)。치료후연구조폐공능개선현저호우대조조(P<0.05)。결론:포지내덕치료지기관효천급성발작료효현저,치득림상추엄사용。
Objective:To analyze the efficacy of budesonide in the treatment of bronchial asthma with acute exacerbation and the impact on lung function.Method:104 cases of patients with bronchial asthma combined acute exacerbation from April 2012 to April 2014 were randomly divided into the control group and the research group,with 52 cases in each group.The control group received routine treatment,and the research group received inhaled budesonide inhalation therapy based on the routine treatment. We observed the clinical integration,conventional indicators and indicators of lung function before and after the treatment.Results:After the treatment,the clinical symptom score of the research group was lower than that of the control group,and the conventional indicators improved more significantly compared with that of the control group(P<0.05).The lung function of the research group improved more significantly higher than that of the control group(P<0.05).Conclusion:Budesonide in the treatment of patients with bronchial asthma combined acute exacerbation obtained significant effect and was worthy of clinical use.